Exercise and GLP-1 to improve insulin and muscle blood flow
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at whether doing exercise and a GLP-1 medicine (liraglutide or similar) can improve how your body uses insulin and how blood flows to your muscles. It is aimed at adults with metabolic syndrome who do not already have diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 21 and 60 years old
- Have a BMI over 25 but not above 35, and your weight must be stable recently
- Meet at least 3 out of 5 metabolic syndrome signs (waist size, triglycerides, HDL, blood pressure, or fasting glucose)
- Have no history of diabetes and have never used diabetes medicines
- Be able to safely do an exercise program and not have done regular moderate/high exercise recently
- Not be pregnant or breastfeeding, and not be allergic to perflutren
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if empagliflozin, a medication typically used for diabetes, can help people with metabolic syndrome (a cluster of conditions like large waist size, high blood sugar, and high blood pressure). It may improve health and reduce the risk of heart disease.
This study tests whether a diabetes medication called an SGLT2 inhibitor can reduce inflammation in body fat and improve blood vessel function in people with metabolic syndrome. It may help prevent heart disease and other complications.
This study tests whether short walks and simple strength exercises after meals can help control blood sugar in adults with metabolic syndrome. It may offer an easy way to improve glucose levels without intense workouts.
This study tests if combining exercise with a drug called liraglutide improves blood vessel health and insulin sensitivity in people with type 2 diabetes. It looks at whether these treatments work better together or alone.
This study tests whether a 12-week program of exercise and personalized nutrition can help adults who are obese and taking GLP-1 weight-loss medications maintain muscle and bone while losing fat. It aims to improve strength, fitness, and overall function during treatment.
This trial tests whether combining a GLP-1 medication (a type of diabetes drug that also helps with weight loss) with an exercise program can improve physical function in people with obesity. If you are obese and have trouble with daily activities, this study may help you become more mobile and healthier.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.